Successful Treatment of Protein-Losing Enteropathy Induced by Intestinal Lymphangiectasia in a Liver Cirrhosis Patient with Octreotide: A Case Report.
10.3346/jkms.2004.19.3.466
- Author:
Hang Lak LEE
1
;
Dong Soo HAN
;
Jin Bae KIM
;
Yong Chul JEON
;
Joo Hyun SOHN
;
Joon Soo HAHM
Author Information
1. Department of Internal Medicine, Hanyang University Kuri Hospital, Guri, Korea. hands@hanyang.ac.kr
- Publication Type:Case Report
- Keywords:
Lymphagiectasis, Intestinal;
Protein-Losing Enteropathies;
Octreotide
- MeSH:
Adolescent;
Adult;
Duodenum/pathology;
Female;
Hepatitis B/complications;
Hepatitis B Virus/metabolism;
Human;
Intestinal Diseases/*drug therapy/virology;
Jejunum/pathology;
Liver Cirrhosis/*drug therapy/virology;
Lymphangiectasis, Intestinal/*drug therapy/virology;
Male;
Middle Aged;
Octreotide/*pharmacology;
Protein-Losing Enteropathies/*drug therapy
- From:Journal of Korean Medical Science
2004;19(3):466-469
- CountryRepublic of Korea
- Language:English
-
Abstract:
A 47-yr-old man with hepatitis B virus associated liver cirrhosis was admitted to our hospital with diarrhea and generalized edema and diagnosed as protein-losing enteropathy due to intestinal lymphangiectasia by intestinal biopsy and 99mTc albumin scan. During hospitalization, he received subcutaneous octreotide therapy. After 2 weeks of octreotide therapy, follow-up albumin scan showed no albumin leakage, and the serum albumin level was sustained. We speculate that liver cirrhosis can be a cause of intestinal lymphangiectasia and administration of octreotide should be considered for patients with intestinal lymphangiectasia whose clinical and biochemical abnormalities do not respond to a low-fat diet.
